Search Results - "Chan, T.A."

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group by De Mattos-Arruda, L., Vazquez, M., Finotello, F., Lepore, R., Porta, E., Hundal, J., Amengual-Rigo, P., Ng, C.K.Y., Valencia, A., Carrillo, J., Chan, T.A., Guallar, V., McGranahan, N., Blanco, J., Griffith, M.

“…The use of next-generation sequencing technologies has enabled the rapid identification of non-synonymous somatic mutations in cancer cells. Neoantigens are…”
Get full text

PIK3CA Activating Mutations Are Associated With Decreased Local Control in Lung Cancer Brain Metastases Treated With Radiation by Lockney, N.A, Pei, X, Blumberg, L.E, Chan, T.A, Yamada, Y, Yang, T.J, Beal, K

Get full text

Initial Report on Safety and Lesion Response of Melanoma Brain Metastases After Stereotactic Radiosurgery or Hypofractionated Radiation Therapy in Patients Receiving Concurrent Pembrolizumab by Anderson, E.S, Postow, M.A, Young, R, Chan, T.A, Yamada, Y, Beal, K

Get full text

Concurrent Radiation Therapy (RT), Ipilimumab (Ipi) and/or Nivolumab (Nivo) on a Phase 1 Clinical Trial by Barker, C.A, Postow, M.A, Kronenberg, S.A, Ma, J, Yamada, Y, Beal, K, Chan, T.A, Callahan, M.K, Wolchok, J.D

Get full text

Clinical Outcomes of Patients With Limited Brain Metastases Treated With Hypofractionated Conformal Radiation Therapy by Yang, T.J, Wang, D.G, Pei, X, Kohutek, Z.A, Lanning, R.M, Blumberg, L.E, Chan, T.A, Yamada, Y, Beal, K

Get full text

Patterns of Salvage Treatment for High Grade Glioma in Patients Who Received Upfront Temozolomide by Escorcia, F.E, Spratt, D.E, Folkert, M.R, Zumsteg, Z.S, Chan, T.A, Omuro, A.M, Gutin, P.H, Yamada, Y, Beal, K

Get full text

Clinical Outcomes of Salvage Partial Brain Radiation Therapy for Local Recurrence After Stereotactic Radiosurgery in the Setting of Brain Metastases by Lanning, R, Yang, T, Kohutek, Z, Brennan, C.W, Chan, T.A, Yamada, Y, Beal, K

Get full text

Genomic Analysis of Exceptional Responders to Low-Dose Radiation Therapy Reveals Somatic Mutations in ATM by Ma, J, Setton, J, Blecua Carrillo Albornoz, P, Barker, C.A, Lok, B.H, Beal, K, Powell, S.N, Lee, N, Chan, T.A, Riaz, N

Get full text

A Validation Study of the Temporal Relation of Postoperative Radiation Therapy With Temozolomide for Glioblastoma Multiforme: Is the RTOG RPA Enough? by Spratt, D.E, Folkert, M, Chan, T.A, Pentsova, E, Beal, K, Yamada, Y

Get full text

Radiographic Features, Patterns of Treatment Failure, and Clinical Outcomes in 56 Cases of Molecularly Subtyped Glioblastoma Multiforme Patients by LaPlant, Q, Pitter, K, Young, R.J, Yamada, Y, Chan, T.A, Huse, J.T, Brennan, C.W, Beal, K

Get full text

Clinical Experience With 2 Cranial Frameless Stereotactic Radiosurgery (fSRS) Systems by Li, G, Ballangrud, A, Chan, M.F, Ma, R, Beal, K, Chan, T.A, Yamada, Y, Mechalakos, J.G, Hunt, M.A

Get full text

Lack of Survival Benefit in Patients with Anaplastic Astrocytoma Treated with Temozolomide during Radiotherapy by Barker, C.A, Chang, M, Beal, K, Chan, T.A

Get full text

Prognostic Implications of Receptor Status and Extracranial Disease in Patients With Breast Cancer Brain Metastases Treated With Stereotactic Radiosurgery by Yang, T, Oh, J, Folkert, M, Morikawa, A, Seidman, A.D, Yamada, Y, Chan, T.A, Beal, K

Get full text

Addition of FDG-PET Decreases Interobserver Variability in Delineation of the Lumpectomy Cavity for Patients Who Have Poor Cavity Visualization by CT Alone by de Souza-Lawrence, L.M, Ford, E, Asrari, F, Frassica, D.A, Myers, L, Chan, T.A, Zellars, R

Get full text

Stereotactic Radiosurgery and Radiation Therapy for the Treatment of Brain Metastases in Thyroid Carcinoma by Roy, D, Laufer, M, Beal, K, Yamada, Y, Gutin, P.H, Brennan, C.W, Tabar, V, Chan, T.A

Get full text

Ipilimumab and Stereotactic Radiosurgery for Melanoma Brain Metastases by Kiess, A.P, Wolchok, J.D, Barker, C.A, Postow, M.A, Tabar, V, Chan, T.A, Yamada, Y, Beal, K

Get full text

Phase II Study of Bevacizumab (BEV), Temozolomide (TMZ) and Hypofractionated Stereotactic Radiotherapy (HFSRT) for Newly Diagnosed Glioblastoma (GBM) by Beal, K, Omuro, A, Karimi, S, Correa, D, Chan, T.A, DeAngelis, L.M, Yamada, Y, Abrey, L.E, Gutin, P.H

Get full text

Outcome of Patients Undergoing Radiotherapy for High Grade Glioma While Taking the Histone Deacetylase Inhibitor, Valproic Acid by Barker, C.A, Camphausen, K.A, Tofilon, P.J, Chan, T.A

Get full text

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic by Chan, T.A., Yarchoan, M., Jaffee, E., Swanton, C., Quezada, S.A., Stenzinger, A., Peters, S.

“…Treatment with immune checkpoint blockade (ICB) with agents such as anti-programmed cell death protein 1 (PD-1), anti-programmed death-ligand 1 (PD-L1), and/or…”
Get full text

Syne1 Promoter Hypermethylation as a Predictor of Tumor Aggressiveness in Primary Breast Cancer by Rimner, A, Ho, A.Y, Ahuja, N, Schuebel, K.E, Baylin, S.B, Gerald, W.L, Chan, T.A

Get full text